Clinical Trials
17 trialsNCT07072221 2025-07-18
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
The First Affiliated Hospital of Soochow University
Phase NA Recruiting
NCT06671717 2024-11-06
Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
Peking University People's Hospital
Phase NA Not yet recruiting
NCT04045470 2024-10-08
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06509945 2024-08-01
Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Recruiting
NCT06211881 2024-01-18
Chi-GVM Regimen for the Treatment of R/R PTCL
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT05444712 2023-09-28
TRANSCRIPT
Hospices Civils de Lyon
Phase NA Recruiting
NCT00536601 2021-04-22
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Roswell Park Cancer Institute
Phase NA Completed
NCT00014235 2020-01-21
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Fred Hutchinson Cancer Center
Phase NA Completed
NCT00003196 2019-12-27
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
Fred Hutchinson Cancer Center
Phase NA Completed
NCT01408043 2019-06-14
Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
Case Comprehensive Cancer Center
Phase NA Terminated
NCT03268889 2017-08-31
CHOP
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT00112593 2017-05-24
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Fred Hutchinson Cancer Center
Phase NA Completed
NCT03051568 2017-02-13
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT03051581 2017-02-13
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT01841021 2017-01-19
Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT01769911 2015-05-07
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase NA Withdrawn
NCT00514722 2013-08-14
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
University of California, San Francisco
Phase NA Terminated